Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1529-1534

  Konadu, Edward Y ^a   Lin, Feng Ying C ^a   Hó, Vô Anh ^b   Thuy, Nguyen Thi Thanh ^c   Van Bay, Phan ^b   Thanh, Tran Cong ^c   Khiem, Ha Ba ^c   Trach, Dang Duc ^d   Karpas, Arthur B ^a   Li, Jianping ^a   Bryla, Dolores A ^a   Robbins, John B ^a   Szu, Shousun C ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b Huu Nghi Hospital   (Viet Nam)

^c PASTEUR INSTITUTE   (Viet Nam)

^d NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPIC ACID DERIVATIVE; AMINOPYRIDINE DERIVATIVE; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; O ANTIGEN; TETANUS ANTIBODY; TETANUS TOXOID;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALMONELLA ENTERICA; SALMONELLA PARATYPHI; VACCINATION; VIET NAM;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; CHILD, PRESCHOOL; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDES; O ANTIGENS; SALMONELLA PARATYPHI A; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 0033952473     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1529-1534.2000     Document Type: Article

References (66)

1. Acharya, G., T. Butler, M. Ho, P. R. Sharma, M. Tawari, R. K. Adhikari, J. B. Khagda, B. Pokhrel, and U. N. Pathak. 1995. Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol. Am. J. Trop. Med. Hyg. 52:162-165.
2. Adeyokunnu, A., and R. G. Hendrickse. 1980. Salmonella osteomyelitis in childhood. Arch. Dis. Child. 55:175-184.
3. Anand, A. C., V. K. Kataria, W. Singh, and S. K. Chatterjee. 1990. Epidemic multiresistant enteric fever in eastern India. Lancet 335:352.
4. Ashkenazi, S., J. H. Passwell, E. Harley, D. Miron, R. Dagan, N. Farzan, R. Ramon, F. Majadly, D. A. Bryla, A. B. Karpas, J. B. Robbins, R. Schneerson, and the Israel Pediatric Shigella Study Group. 1999. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in adults. J. Infect. Dis. 179:1565-1568.
5. Avery, O. T., and W. F. Goebel. 1933. Chemoimmunological studies on the soluble specific substance of pneumococcus. I. The isolation and properties of the acetyl polysaccharide of pneumococcus type 1. J. Exp. Med. 58:731-755.
6. Baumgartner, J. D., D. Heumann, T. Calandra, and M. P. Glauser. 1991. Antibodies to lipopolysaccharide after immunization of humans with rough mutant Escherichia coli. J. Infect. Dis. 163:769-772.
7. Bhutta, Z., B. J. Farooqui, and A. W. Sturm. 1992. Eradication of a multiple drug resistant Salmonella paratyphi A causing meningitis with ciprofloxacin. J. Infect. 25:215-219.
8. 1 predicted by semi-empirical hard-sphere (HSEA) calculations. Carbohydr. Res. 130:23-34.
9. 13C-nudear magnetic resonance spectroscopy. Carbohydr. Res. 130:35-53.
10. Carlin, N. I. A., S. B. Svenson, and A. A. Lindberg. 1987. Role of monoclonal O-antigen antibody epitope specificity and isotype in protection against experimental mouse typhoid. Microb. Pathog. 2:171-183.
11. Carter, P. B., and F. M. Collins. 1974. Growth of typhoid and paratyphoid bacilli in intravenously infected mice. Infect. Immun. 10:816-822.
12. Chalker, R. B., and M. J. Blaser. 1988. A review of human salmonellosis. III. Magnitude of Salmonella infection in the United States. Rev. Infect. Dis. 10:111-124.
13. Chu, C., B. Liu, D. Watson, S. C. Szu, D. Bryla, J. Shiloach, R. Schneerson, and J. B. Robbins. 1991. Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 bound to tetanus toxoid. Infect. Immun. 59:4450-4458.
14. Claesson, B. O., B. Trollfors, T. Lagergard, J. Taranger, D. Bryla, G. Otterman, T. Cramton, Y. Yang, C. B. Reimer, J. B. Robbins, and R. Schneerson. 1988. Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children. J. Pediatr. 112:695-702.
15. Cohen, D., S. Ashkenazi, M. S. Green, M. Gdalevich, G. Robin, R. Slepon, M. Yavzori, N. Orr, C. Block, I. Ashkenazi, J. Shemer, D. N. Taylor, T. L. Hale, J. C. Sadoff, D. Pavliakora, R. Schneerson, and J. B. Robbins. 1997. Double-blind vaccine-controlled randomized efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Lancet 349:155-159.
16. Colwell, D. E., S. M. Michalek, D. E. Briles, J. Emilio, and J. R. McGhee. 1984. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium. J. Immunol. 133:950-957.
17. Cygler, M., D. R. Rose, and D. R. Bundle. 1991. Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science 253:442-445.
18. DeMaria, A., M. A. Johns, H. Berberich, and W. R. McCabe. 1988. Immunization with rough mutants of Salmonella minnesota: initial studies in human subjects. J. Infect. Dis. 158:301-311.
19. Ebong, W. W. 1986. Acute osteomyelitis in Nigerians with sickle cell disease. Ann. Rheum. Dis. 45:911-915.
20. Edwards, P. R., and D. W. Bruner. 1943. The occurrence and distribution of Salmonella types in the United States. J. Infect. Dis. 72:58-61.
21. Edwards, P. H., and W. H. Ewing. 1972. Identification of Enterobacteriaceae, 3rd ed., p. 175. Burges Publishing Company, Minneapolis, Minn.
22. Escamilla, J., H. Florez-Ugarte, and M. E. Kilpatrick. 1986. Evaluation of blood clot cultures for isolation of Salmonella typhi, Salmonella paratyphi A, and Brucella melitensis. J. Clin. Microbiol. 24:388-390.
23. Fouquey, C., J. Polonsky, E. Lederer, O. Westphal, and O. Luderitz. 1958. Synthesis of 3,6-dideoxy-D-ribo-hexose (3,6-dideoxy-D-glucose) and its identification with paratose. Nature 182:944.
24. Gerichter, C. B. 1960. The dissemination of Salmonella typhi, Salmonella paratyphi A, and Salmonella paratyphi B through the organs of the white mouse by oral infection. J. Hyg. Camb. 58:307-319.
25. Hafiz, S., S. W. Khan, R. Shariff, I. Yazdani, Y. Syed, and T. Hafiz. 1993. Epidemiology of salmonellosis and its sensitivity in Karachi. J. Pak. Med. Assoc. 43:178-179.
26. Hargrett-Bean, N. T., A. T. Pavia, and R. V. Tauxe. 1988. Salmonella isolates from humans in the United States, 1984-1986. Morbid. Mortal. Weekly Rep. 37(SS-2):25-31.
27. Hellerqvist, C. G., B. Lindberg, K. Samuelsson, and A. A. Lindberg. 1971. Structural studies on the O-specific side-chains of the cell-wall lipopolysaccharide from Salmonella paratyphi A var. durazzo. Acta Chem. Scand. 25: 955-961.
28. Hien, T. T., D. B. Bethell, N. T. T. Hoa, J. Wain, T. S. Diep, L. T. Phi, B. M. Cuong, N. M. Duong, P. T. Thanh, A. L. Walsh, N. P. J. Day, and N. J. White. 1995. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin. Infect. Dis. 20:915-923.
29. Jude, A., and L. Le Minor. 1948. Salmonella isolées en Indochine au cours d'affections typho-paratyphoidiques. Bull. Soc. Pathol. Exot. 41:129-133.
30. Kabat, E. A., and A. E. Bezer. 1958. The effect of variation in molecular weight on the antigenicity of dextran in man. Arch. Biochem. Biophys. 78:306-310.
31. Kapil, A., A. Sood, V. P. Reddaiah, B. Das, and P. Seth. 1997. Paratyphoid fever due to Salmonella enterica serotype paratyphi A. Emerg. Infect. Dis. 3:407.
32. Kauffmann, F. 1954. Enterobacteriaceae, 2nd ed., p. 107. Munksgaard, Copenhagen, Denmark.
33. Kohn, J., and M. Wilchek. 1983. 1-Cyano-4-dimethylamino pyridinium tetrafluoroborate as a cyanylating agent for the covalent attachment of ligand to polysaccharide resins. FEBS Lett. 154:209-210.
34. Konadu, E., J. B. Robbins, J. Shiloach, D. A. Bryla, and S. C. Szu. 1994. Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines. Infect. Immun. 62:5048-5054.
35. Konadu, E., J. Shiloach, D. A. Bryla, J. B. Robbins, J. B., and S. C. Szu. 1996. Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid, with emphasis on the role of O-acetyls. Infect. Immun. 64:2709-2715.
36. Lasserre, R., R. P. Sangalang, and L. Santiago. 1991. Three-day treatment of typhoid fever with two different doses of ceftriaxone, compared to 14-day therapy with chloramphenicol: a randomized trial. J. Antimicrob. Chemother. 28:765-772.
37. Lee, S.-C., P.-H. Yang, W.-B. Shieh, and R. Lasserre. 1994. Bacteremia due to non-typhi Salmonella: analysis of 64 cases and review. Clin. Infect. Dis. 19:693-696.
38. Lees, A., B. L. Nelson, and J. J. Mond. 1996. Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents. Vaccine 14:190-198.
39. Lepage, P., J. Bogaerts, C. van Goethem, M. Ntahorutaba, F. Nsengumuremyi, D. G. Hitimana, J. Vandepitte, J.-P. Butzler, and J. Levy. 1987. Community-acquired bacteremia in African children. Lancet i:1458-1461.
40. Leung, M. 1995. Simultaneous infection by a sensitive and a multiresistant strain of Salmonella paratyphi A. J. Infect. 30:181-183.
41. Mahanta, J. 1994. Drug sensitivity of Salmonella paratyphi A isolated from a suspected outbreak of fever in Dulijan. J Indian Med. Assoc. 92:49-50.
42. Nesbitt, A., and N. B. Mirza. 1989. Salmonella septicaemias in Kenyan children. J. Trop. Pediatr. 35:35-39.
43. Nguyen, T. A., H. K. Ha, and T. D. Nguyen. 1993. Typhoid fever in South Vietnam, 1990-1993. Bull. Soc. Pathol. Exot. 86:476-478.
44. Nournand, A., M. Ziai, and A. C. Tahernia. 1971. Typhoid-paratyphoid fevers in infancy. Clin. Pediatr. 10:272-274.
45. Ørskov, F., and I. Ørskov. 1983. Summary of a workshop on the clone concept in the epidemiology, taxonomy, and evolution of the Enterobacteriaceae and other bacteria. J. Infect. Dis. 148:346-357.
46. Phillips, I., and B. Wharton. 1968. Acute bacterial infection in kwashiorkor and marasmus. Br. Med. J. 1:407-409.
47. Rao, P. S., I. Bairy, P. V. Rao, and P. G. Shivananda. 1994. Multiresistant Salmonella paratyphi 'A' infection in coastal Karnataka. J. Assoc. Physicians India 42:929.
48. Raynal, J. H., and J. Fournier. 1947. Les salmonelles à Changhaï. Med. Trop. 7:199-237.
49. Reeves, M. W., G. M. Evins, A. A. Heiba, B. D. Plikaytis, and J. J. Farmer III. 1989. Clonal nature of Salmonella typhi and its genetic relatedness to other salmonellae as shown by multilocus enzyme electrophoresis and proposal of Salmonella bongori comb. nov. J. Clin. Microbiol. 27:313-320.
50. Robbins, J. B., C. Y. Chu, and R. Schneerson. 1992. Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-speciflc polysaccharide of their lipopolysaccharides. Clin. Infect. Dis. 15:346-361.
51. Robbins, J. B., and R. Schneerson. 1990. Polysaccharide-protein conjugates: a new generation of vaccines. J. Infect. Dis. 161:821-832.
52. Robbins, J. B., R. Schneerson, and S. C. Szu. 1995. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171:1387-1398.
53. Rowe, B., and R. J. Gross. 1984. Genus II. Salmonella, p. 423-458. In N. R. Krieg and J. G. Holt (ed.), Bergey's manual of systemic bacteriology, vol. 1. The Williams & Wilkins Co., Baltimore, Md.
54. Sarnaik, S., J. Kaplan, G. Schiffman, D. A. Bryla, J. B. Robbins, and R. Schneerson. 1990. Studies on pneumococcus vaccine alone or mixed with DTP and on pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in 2- to 5-year-old children with sickle cell anemia. Pediatr. Infect. Dis. 9:181-186.
55. Schwartz, E., D. R. Schlim, M. Eaton, N. Jenks, and R. Houston. 1988. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal. Arch. Intern. Med. 150:349-351.
56. Selander, R. K., P. Beltran, N. H. Smith, R. Helmuth, F. A. Rubin, D. J. Kopecko, K. Ferris, B. D. Tall, A. Cravioto, and J. M. Mussen 1990. Evolutionary genetic relationships of clones of Salmonella serovars than cause human typhoid and other enteric fevers. Infect. Immun. 58:2262-2275.
57. Simanjuntak, C. H., F. P. Paleologo, N. H. Punjabi, R. Darmowigoto, H. Totosudirjo, P. Haryanto, E. Suprijanto, N. D. Witham, and S. L. Hoffman. 1991. Oral immunization against typhoid fever in Indonesia with Ty21a vaccine. Lancet 338:1055-1059.
58. Svensson, S. B., and A. A. Lindberg. 1981. Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice. Infect. Immun. 32:490-496.
59. Syverton, J. T., R. E. Ching, and A. B. Smith. 1946. Typhoid and paratyphoid A in immunized military personnel. JAMA 131:507-514.
60. Szu, S. C., X. Li, R. Schneerson, J. H. Vickers, D. Bryla, and J. B. Robbins. 1989. Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high-or lower-molecular-weight Vi. Infect. Immun. 57:3823-3827.
61. Szu, S. C., R. Gupta, and J. B. Robbins. 1994. Induction of serum vibriocidal antibodies by O-specific polysaccharide-protein conjugate vaccines for prevention of cholera, p. 381-394. In I. K. Wachsmuth, P. A. Blake, and O. Olsvik (ed.), Vibrio cholerae. American Society for Microbiology, Washington, D.C.
62. Thisyakorn, U., P. Mansuwan, and D. N. Taylor. 1987. Typhoid and paratyphoid fever in 192 hospitalized children in Thailand. Am. J. Dis. Child. 141:862-865.
63. Verghese, S. L., R. Manonmani, S. Balasubramanian, and S. Chandrasekharan. 1992. Multi-drug resistance in salmonellae isolated from enteric fever cases at Porur - a semi urban area near Madras City. J. Commun. Dis. 24:12-15.
64. Watson, D. C., J. B. Robbins, and S. C. Szu. 1992. Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine. Infect. Immun. 60:4679-4686.
65. World Health Organization Expert Committee on Biologic Standardization. 1993. Requirements on Vi polysaccharide for typhoid. W. H. O. Tech. Rep. Ser. 43:14-32.
66. Zimmerman, L. E., M. Cooper, and C. D. Graber. 1952. Bacteriologie studies in an outbreak of salmonellosis in Korea. Am. J. Hyg. 56:252-264.